Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19

10.1001/jama.2020.1585

Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020. [cited 2020 Apr 28]; Available from: https://coronavirus.jhu.edu/map.html.

10.1038/s41586-020-2196-x

CDC China. COVID-19 Prevention and Control. 2020

[cited 2020 Apr 28]. Available from: http://www.chinacdc.cn/en/COVID19/202002/P020200310326343385431.pdf.

10.1097/JCMA.0000000000000270

10.1128/JVI.02501-05

10.1016/j.ijantimicag.2020.105924

10.1038/s41591-020-0820-9

10.1002/jmv.25681

Worldometer. COVID-19 coronavirus pandemic. 2020; [cited 2020 Apr 28]; Available from: https://www.worldometers.info/coronavirus/.

CDC. Information for Clinicians on Investigational Therapeutics for Patients with COVID-19. 2020. CDC.

10.1073/pnas.0403492101

World Health Organization (WHO). DRAFT landscape of COVID-19 candidate vaccines-20 April 2020. 2020.

10.1128/JVI.02696-06

10.1128/JVI.77.15.8263-8271.2003

10.1001/jama.2016.4218

10.1007/s40475-020-00201-6

10.1038/d41573-020-00073-5

Inovio. Focusing on treating and preventing cancer and infectious disease. 2020; [cited 2020 Jul 8]. Available from: https://www.inovio.com/.

R.D., Membrane fusion proteins derived from reovirus. 2012.

La Merie Publishing. Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform. 2020; [cited 2020 Jul 8]. Available from: https://pipelinereview.com/index.php/2020031974059/Vaccines/Entos-Pharmaceuticals-Is-Developing-a-DNA-Vaccine-Against-COVID-19-Using-Its-Fusogenix-Nanomedicine-Platform.html.

10.1016/j.vaccine.2017.10.071

Moderna. Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus. 2020.

Arena CT. BioNTech and Pfizer get German approval for Covid-19 vaccine trial. 2020; [cited 2020 Jul 8]. Available from: https://www.clinicaltrialsarena.com/news/biontech-pfizer-covid-19-vaccine-trial/.

University of Oxford. COVID-19 Oxford Vaccine Trial. 2020; [cited 2020 Jul 8]. Available from: https://covid19vaccinetrial.web.ox.ac.uk/.

10.1038/nrg1066

La Merie Biologics. Clover initiates development of recombinant subunit-trimer vaccine for Wuhan Coronavirus (2019-nCoV). 2020; [cited 2020 Jul 8]. Available from: https://pipelinereview.com/index.php/2020012873644/Vaccines/Clover-Initiates-Development-of-Recombinant-Subunit-Trimer-Vaccine-for-Wuhan-Coronavirus-2019-nCoV.html.

10.1158/1078-0432.CCR-10-0085

10.1517/14712590802614538

Technology, P. Coronavirus: Vir Biotechnology and Novavax announce vaccine plans. 2020

[cited 2020 Jul 8]. Available from: https://www.pharmaceutical-technology.com/news/coronavirus-vir-biotechnology-novavax-vaccine/.

10.1021/acscentsci.0c00272

NIH. Therapeutic Options for COVID-19 Currently Under Investigation. 2020; [cited 2020 Jul 8]. Available from: https://covid19treatmentguidelines.nih.gov/therapeutic-options-under-investigation/.

10.1126/scitranslmed.abb5883

10.1136/bmj.m1610

10.1073/pnas.1922083117

10.1126/scitranslmed.aal3653

10.1056/NEJMoa2007016

ClinicalTrials.gov. Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19. 2020.

ClinicalTrials.gov. Evaluation of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection. 2020; [cited 2020 Jul 8]. Available from: https://clinicaltrials.gov/ct2/show/NCT04291729?recrs=de&cond=COVID-19&draw=2&rank=12.

10.1136/bmj.m1432

10.1097/00000441-196707000-00008

10.1080/14787210.2017.1305888

10.1186/1743-422X-2-69

ChiCTR, C.C.T.R. Study on the therapeutic effect of hydroxychloroquine on new coronavirus pneumonia (COVID-19). 2020; [cited 2020 Jul 8]. Available from: http://www.chictr.org.cn/showproj.aspx?proj=48880.

10.1016/j.ijantimicag.2020.105949

NIH panel warns against use of hydroxychloroquine to treat Covid-19. 2020.

10.1056/NEJMoa2001282

Therapy, R.E.o.C. and (RECOVERY). Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. 2020.

Horby P, et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report.medRxiv, 2020.

guidelines, N.C.t. The National Institutes of Health COVID-19 Treatment Guidelines Panel Provides Recommendations for Dexamethasone in Patients with COVID-19. 2020.

10.1007/s10096-004-1271-9

10.1111/j.1469-0691.2004.00956.x

WHO. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease; [cited 2020 Jul 8]. 2014. Available from: https://www.who.int/csr/resources/publications/ebola/convalescent-treatment/en/.

10.1186/s40064-015-1490-9

10.1093/cid/ciq106

10.1126/science.aaf0972

10.1126/science.aaf1279

10.1016/j.vetimm.2009.12.004

NIH. Hyperimmune Plasma for Critical Patients With COVID-19 (COV19-PLASMA); [cited 2020 Jul 8]. 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04321421.

ClinicalTrials.gov. Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients – Sarilumab Trial – CORIMUNO-19 – SARI (CORIMUNO-SARI); [cited 2020 Jul 8]. 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04324073?recrs=de&cond=COVID-19&draw=2&rank=36.

ClinicalTrials.gov. Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis. 2020; [cited 2020 Jul 8]. Available from: https://clinicaltrials.gov/ct2/show/record/NCT04315480?recrs=de&cond=COVID-19&draw=2&rank=32.

BioSpace. China’s CanSino Prepares to Advance COVID-19 Vaccine Candidate into Phase II. 2020; [cited 2020 Jul 8]. Available from: https://www.biospace.com/article/china-s-cansino-prepares-to-advance-covid-19-vaccine-candidate-into-phase-ii/.

Mittal P. Chugai Pharmaceutical and Zhejiang Hisun Pharmaceutical, in Coronavirus research- where we are? 2020.

Puckey M. Can Leronlimab (PRO 140) be used to treat COVID-19 (coronavirus)? 2020; [cited 2020 Jul 8]. Available from: https://www.drugs.com/medical-answers/leronlimab-pro-140-treat-covid-19-coronavirus-3535182/.

Distributed Bio. Our Race for a COVID-19 Therapeutic. 2020; [cited 2020 Jul 8]. Available from: https://www.distributedbio.com/covid19.

News, G.G.E.a.B. Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development. 2020; [cited 2020 Jul 8]. Available from: https://www.genengnews.com/a-lists/vanquishing-the-virus-160-covid-19-drug-and-vaccine-candidates-in-development/2/.

Technology, P. Incyte begins Phase III trial of ruxolitinib to treat Covid-19. 2020

[cited 2020 Jul 8]. Available from: https://www.pharmaceutical-technology.com/news/incyte-ruxolitinib-covid-19-trial/.

Vaccinations, P. INO-4800 DNA Coronavirus Vaccine. 2020

[cited 2020 Jul 8]. Available from: https://www.precisionvaccinations.com/vaccines/ino-4800-dna-coronavirus-vaccine.

Johnson J. Johnson & Johnson announces a lead vaccine candidate for COVID-19; landmark new partnership with U.S. Department of Health & Human Services; and commitment to supply one billion vaccines worldwide for emergency pandemic use. 2020; [cited 2020 Jul 8]. Available from: https://www.jnj.com/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19-landmark-new-partnership-with-u-s-department-of-health-human-services-and-commitment-to-supply-one-billion-vaccines-worldwide-for-emergency-pandemic-use.

NIH. Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection (COVID-19). 2020; [cited 2020 Jul 8]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04283461.

European Pharmaceutical Review. Global trial to evaluate Kevzara®(sarilumab) as COVID-19 therapy initiated. 2020; [cited 2020 Jul 8]. Available from: https://www.europeanpharmaceuticalreview.com/news/116003/global-trial-to-evaluate-kevzara-sarilumab-as-covid-19-therapy-initiated/.

PMLIVE. FDA approves Roche’s Actemra COVID-19 trial. 2020; [cited 2020 Jul 8]. Available from: http://www.pmlive.com/pharma_news/fda_approves_roches_actemra_covid-19_trial_1329887.

VICTOR TANGERMANN, F. First peer-reviewed coronavirus vaccine trial shows promising results in mice. 2020; [cited 2020 Jul 8]. Available from: https://www.sciencealert.com/scientists-in-pittsburgh-say-they-ve-already-developed-a-covid-19-vaccine-candidate.

NIH. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in participants with severe Coronavirus Disease (COVID-19). 2020; [cited 2020 Jul 8]. Available from: https://clinicaltrials.gov/ct2/show/NCT04292899.

Illumina.Our software toolkit supports the fight against SARS-CoV-2. 2020. [cited 2020 Apr 21]. Available from: https://www.illumina.com/informatics/specialized-bioinformatics-applications/coronavirus-software.html.

The Science Advisory Board. Arbor offers NGS coronavirus panel to researchers for free. 2020; [cited 2020 Jul 8]. Available from: https://www.scienceboard.net/index.aspx?sec=sup&sub=can&pag=dis&ItemID=493.

Black S. Enrichment NGS emerges as surveillance tool for coronavirus. 2020; [cited 2020 Jul 8]. Available from: https://www.scienceboard.net/index.aspx?sec=sup⊂=gen&pag=dis&ItemID=454.

10.1016/S1473-3099(20)30162-6

10.1016/S1473-3099(20)30144-4

10.1016/j.ijid.2020.03.031

10.1073/pnas.0610941104

Ainslie KEC, et.al. Report 11 – Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. 2020; [cited 2020 Jul 8]. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-11-china-exiting-social-distancing/.

Park SW, Sun K, Viboud C, et al. Potential roles of social distancing in mitigating the spread of coronavirus disease 2019 (COVID-19) in South Korea.Version 1. medRxiv. 2020; p. 2020.03.27.20045815.

He J, Chen G, Jiang, Y, et al. Comparative Analysis of COVID-19 Transmission Patterns in Three Chinese Regions vs. South Korea, Italy and Iran. medRxiv. 2020; p. 2020.04.09.20053223.

Organisation, W.H. Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages. 2020; [cited 2020 Jul 8]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331695/WHO-2019-nCov-IPC_PPE_use-2020.3-eng.pdf.

Organisation, W.H. Advice on the use of masks in the context of COVID-19. 2020; [cited 2020 Jul 8]. Available from: https://www.who.int/publications-detail/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak.

Centers for Disease and Control and Prevention. Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission. 2020.

10.1503/cmaj.1031700

Verbeek JH, 2020, Cochrane Database Syst Rev, 4, CD011621

10.1001/jama.2020.4770

10.1001/jama.2020.5317

Food, U.S. and D. Administration. Investigating Decontamination and Reuse of Respirators in Public Health Emergencies. 2020; [cited 2020 Jul 8]. Available from: https://www.fda.gov/emergency-preparedness-and-response/mcm-regulatory-science/investigating-decontamination-and-reuse-respirators-public-health-emergencies.

10.1177/1535676020919932

10.1016/S2213-2600(20)30134-X

Simmons S. COVID-19: Italy’s new measures to tackle the shortage of masks and PPE. 2020; [cited 2020 Jul 8]. Available from: https://www.simmons-simmons.com/en/publications/ck7yxh7p00v1e0905zzvralrl/covid-19-italy-s-new-measures-to-tackle-the-shortage-of-masks-and-ppe.

The Times of India. 0 to 12,000/day: How India scaled up PPE production. 2020; [cited 2020 Jul 8]. Available from: https://timesofindia.indiatimes.com/india/0-to-12,000/day-how-india-scaled-up-ppe-production/articleshow/75038389.cms.

Organization WH. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance. 2 March 2020. 2020.

10.1001/jama.2020.6170

Gossner CGaO. Group testing against Covid-19. 2020.

10.1101/2020.04.03.024216

Center, S.M.N.Testing pooled samples for COVID-19 helps Stanford researchers track early viral spread in Bay Area. 2020; [cited 2020 Jul 8]. Available from: http://med.stanford.edu/news/all-news/2020/04/testing-pooled-samples-to-track-early-spread-of-virus.html.

India Today. Centre allows Covid-19 pool testing, plasma therapy in Maharashtra. 2020. Available from: Testing pooled samples for COVID-19 helps Stanford researchers track early viral spread in Bay Area.

Salathe M, 2020, Swiss Med Wkly, 150, w20225, 10.4414/smw.2020.20457

10.1093/jtm/taaa039

10.2807/1560-7917.ES.2020.25.13.2000280

10.1001/jamainternmed.2020.1447

10.1016/S2214-109X(20)30074-7

10.1056/NEJMoa2002032

10.1007/s00134-020-05979-7

10.1093/jtm/taaa021

10.1016/j.jhin.2020.03.008

10.1016/S0140-6736(20)30627-9

Nacoti M, Catalyst Non-Issue Content, 1, 5

U.S. Department of Health and Human Services. Pandemic Influenza Plan. 2017

[cited 2020 Jul 8]. Available from: https://www.cdc.gov/flu/pandemic-resources/pdf/pan-flu-report-2017v2.pdf.

10.1056/NEJMsb2005114

10.1378/chest.14-0736

10.1001/jama.2020.5046